Tag

Vaccine Stocks

All articles tagged with #vaccine stocks

business7 months ago•1 min saved

RFK Jr. Dismisses CDC Vaccine Experts, Raising Public Health Concerns

Shares of Moderna and Pfizer remained stable despite U.S. health secretary RFK Jr. firing CDC vaccine advisors, with the market already discounted due to vaccine skepticism and prior stock declines. The overhaul to the CDC's Advisory Committee on Immunization Practices poses risks to vaccine manufacturers, potentially affecting future vaccine recommendations and development costs, but the committee's continuation mitigates some concerns.

via Barron's|

#business #cdc-advisory #moderna

businesshealth1 year ago•3 min saved

"Vaccine Stocks Surge Amid Bird Flu Concerns"

Vaccine stocks Moderna, Novavax, and BioNTech rallied this week due to fears of a bird flu outbreak after new human cases were detected in the U.S. and Australia. The U.S. government is in talks with these companies for potential avian flu vaccines, although the likelihood of a widespread outbreak remains low.

via The Motley Fool|

#biontech #bird-flu #businesshealth

finance1 year ago•4 min saved

Vaccine Stocks Surge Amid Positive Market Trends

Vaccine stocks Moderna, Novavax, and BioNTech rallied this week due to fears of an avian flu outbreak after cases were detected in the U.S. and Australia. Moderna and Pfizer/BioNTech are in talks with the U.S. government for a potential mRNA vaccine program, while Novavax is conducting a pre-clinical study. Despite the stock surge, the likelihood of a widespread avian flu outbreak remains low.

via Yahoo Finance|

#avian-flu #biontech #finance

finance1 year ago•2 min saved

Human Bird Flu Cases Drive Surge in Vaccine Stock Investments

Rising cases of bird flu in humans are driving retail traders to invest in vaccine stocks, with companies like CureVac, Novavax, Moderna, and Pfizer seeing significant gains. This trend mirrors past trading frenzies during outbreaks of diseases like Ebola and Zika, though the long-term impact on revenue remains uncertain.

via Yahoo Finance|

#bird-flu #finance #moderna

finance2 years ago•0 min saved

Novavax Stock Soars on Promising COVID-19 Vaccine Updates

Novavax shares traded higher as rising COVID-19 cases in the US have boosted vaccine stocks. The dominant strain in the US is the EG.5 variant, while a highly mutated strain called BA.2.86 is being monitored. COVID tests seem effective against these variants, but it remains to be seen if a strain becomes more widespread. Fall 2023 boosters appear to work for new variants, but it is unknown if they will be effective against BA.2.86's mutations. Novavax shares closed 10.23% higher at $9.25.

via Benzinga|

#covid-19 #finance #novavax